Tags: DLBCLDiffuse Large B Cell LymphomaBispecific AntibodiesDLBCL Trialstoxicity management
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. | Responses to Mosunetuzumab in Follicular Lymphoma Remain Durable at 3 Years - about 1 year ago Positive Results for Odronextamab in Relapsed/Refractory DLBCL - about 1 year ago | |
| 2 | Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. | ||
| 3 | Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
| 4 | Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | Fixed-Duration Acalabrutinib and Venetoclax Regimens Redefine First-Line Treatment Options for Patients With CLL - 13 days ago Patients With CLL Present Heterogeneously - 10 months ago | |
| 5 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California | Scottish medicines consortium approves CAR T-cell therapy for blood cancer - about 1 month ago | |
| 6 | Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | Year in Review: Follicular Lymphoma - about 1 year ago Can ctDNA Guide Radiation Use in Oligometastatic NSCLC? - about 1 year ago | |
| 7 | Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland | ||
| 8 | Ian Ingram MedPage Today Deputy Managing Editor.
MedPage Today. New York, New York | FDA Approves First CAR-T for Chronic Lymphocytic Leukemia - 9 months ago JAK1 Inhibitor Shows 'Remarkable' Activity in T-Cell Lymphoma - about 1 year ago Frontline Venetoclax-Ibrutinib for CLL Boosts Survival in Fit Patients - about 1 year ago Non-Covalent BTK Inhibitor Approved for CLL - about 1 year ago | |
| 9 | Judy George MedPage Today Medical reporter, writer. | ||
| 10 | Erin Hunter, Associate Editor Pharmacy Times Actor-writer. Nominated BBC Popcorn. London, United Kingdom |